SQS-16682-83701
2 vaccinations
1 coded response
13 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 940 / CA
- Registered
- 2021-02-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-26
Dose 1 — Pfizer-BioNTech
-
2021-02-13
Registered in v-safe
- 2021-02-13
-
2021-02-14
Dose 2 — Pfizer-BioNTech
-
2021-02-16
Survey response — days 1–6 daily, dose 2MedDRA: Chills, Fatigue, Headache, Nausea — Feeling: Good · Site: Pain · Be unable to workFree text: Headache, chills, nausea, fatigue, muscles YESTERDAYMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-16
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-03-02
- 2021-03-08
- 2021-03-14
- 2021-03-21
- 2021-03-28
- 2021-05-17
- 2021-08-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-26 | Pfizer-BioNTech | |
| 2 | 2021-02-14 | Pfizer-BioNTech |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Headache, chills, nausea, fatigue, muscles YESTERDAY
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Nausea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release